JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.04B |
| 2 |
Truist Financial
TFC
|
+$964M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$909M |
| 4 |
Texas Instruments
TXN
|
+$800M |
| 5 |
Johnson & Johnson
JNJ
|
+$783M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.43B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.21B |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$987M |
| 4 |
Microsoft
MSFT
|
+$980M |
| 5 |
CELG
Celgene Corp
CELG
|
+$929M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.95% |
| 2 | Financials | 11.95% |
| 3 | Healthcare | 9.46% |
| 4 | Consumer Discretionary | 8.62% |
| 5 | Industrials | 6.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Enviri
NVRI
$564M
| $7.85M | ﹤0.01% |
341,228
-154,801
| -31% | -$3.24M |
|
2227
Zoom
ZM
$32.2B
| $7.85M | ﹤0.01% |
115,354
+56,948
| +98% | +$3.92M |
|
|
DERM
2228
DELISTED
Dermira, Inc.
DERM
| $7.84M | ﹤0.01% |
517,494
+49,424
| +11% | +$427K |
|
|
VGR
2229
DELISTED
Vector Group Ltd.
VGR
| $7.84M | ﹤0.01% |
825,755
-7,628
| -0.9% | -$66.7K |
|
2230
Sally Beauty Holdings
SBH
$1.55B
| $7.84M | ﹤0.01% |
429,406
+166,855
| +64% | +$2.9M |
|
2231
Four Corners Property Trust
FCPT
$2.76B
| $7.84M | ﹤0.01% |
277,999
+68,184
| +32% | +$1.91M |
|
2232
iShares MSCI United Kingdom ETF
EWU
$4.13B
| $7.83M | ﹤0.01% |
229,641
+229,524
| +196,174% | +$7.47M |
|
2233
PUT
C.H. Robinson
CHRW
$17.5B
| $7.82M | ﹤0.01% |
+100,000
| New | +$7.96M |
|
2234
Designer Brands
DBI
$312M
| $7.81M | ﹤0.01% |
496,434
+36,343
| +8% | +$602K |
|
2235
Steven Madden
SHOO
$3.46B
| $7.81M | ﹤0.01% |
181,508
-30,610
| -14% | -$1.24M |
|
|
FL
2236
PUT
DELISTED
Foot Locker
FL
| $7.8M | ﹤0.01% |
200,000
| – | – |
|
2237
Kemper
KMPR
$1.59B
| $7.79M | ﹤0.01% |
100,469
-20,967
| -17% | -$1.56M |
|
2238
CALL
Chubb
CB
$133B
| $7.78M | ﹤0.01% |
50,000
| – | – |
|
|
2239
PUT
Chubb
CB
$133B
| $7.78M | ﹤0.01% |
50,000
| – | – |
|
2240
Diodes
DIOD
$4.48B
| $7.75M | ﹤0.01% |
137,548
+23,789
| +21% | +$1.1M |
|
2241
Valley National Bancorp
VLY
$8.3B
| $7.74M | ﹤0.01% |
675,781
+139,266
| +26% | +$1.6M |
|
2242
Cabot Corp
CBT
$4.45B
| $7.73M | ﹤0.01% |
162,722
-119,126
| -42% | -$5.53M |
|
2243
WisdomTree US LargeCap Dividend Fund
DLN
$6.45B
| $7.73M | ﹤0.01% |
145,918
+28,952
| +25% | +$1.48M |
|
2244
InterDigital
IDCC
$8.88B
| $7.72M | ﹤0.01% |
141,628
-61,444
| -30% | -$3.39M |
|
|
2245
CALL
Bristol-Myers Squibb
BMY
$132B
| $7.71M | ﹤0.01% |
120,100
-466,500
| -80% | -$26.7M |
|
|
VRTV
2246
DELISTED
VERITIV CORPORATION
VRTV
| $7.71M | ﹤0.01% |
391,828
-37,449
| -9% | -$654K |
|
2247
PUT
Edwards Lifesciences
EW
$53.4B
| $7.7M | ﹤0.01% |
99,000
| – | – |
|
|
AVLR
2248
PUT
DELISTED
Avalara, Inc.
AVLR
| $7.69M | ﹤0.01% |
105,000
+97,500
| +1,300% | +$7.08M |
|
2249
CALL
Fox Class A
FOXA
$27.5B
| $7.68M | ﹤0.01% |
207,300
-144,100
| -41% | -$4.93M |
|
|
INN
2250
Summit Hotel Properties
INN
$656M
| $7.68M | ﹤0.01% |
622,828
+69,229
| +13% | +$831K |
|
Similar funds
JP Morgan Chase's Q4 2019 Portfolio in Review
As of Q4 2019, JP Morgan Chase held 6,136 positions worth $536B, up 6.8% from $502B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q4 2019 filing shows 374 new, 2,295 increased, 2,258 reduced and 490 closed positions. Its largest new stake was XP: 4,912,590 shares worth $189M. The largest sale was Pfizer, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q4 2019 buy was XP: 4,912,590 shares worth $189M.
- JP Morgan Chase added most to iShares 20+ Year Treasury Bond ETF in Q4 2019, an estimated $1.04B increase.
- JP Morgan Chase's biggest Q4 2019 reduction was Pfizer, cutting an estimated $1.43B.
- JP Morgan Chase fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $987M.
- JP Morgan Chase's ten largest holdings make up 17% of its $536B portfolio in Q4 2019.
- JP Morgan Chase opened 374 new positions and closed 490 in Q4 2019.
- JP Morgan Chase's portfolio value rose 6.8% quarter-over-quarter to $536B.
Based on JP Morgan Chase's 13F filing for Q4 2019, filed 11 Feb 2020.